Found: 2
Select item for more details and to access through your institution.
676 - Dupilumab increases levels of bone growth biomarker irrespective of prior use of systemic corticosteroids in children with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.050
- By:
- Publication type:
- Article
Half-Life and Safety of Canakinumab in Pediatric Patients: Comment on the Article by Ilowite et al.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 3, p. 857, doi. 10.1002/art.38992
- By:
- Publication type:
- Article